CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs)

Experimental Cell Research

Volumn 316, Issue 9, 2010, Pages 1553-1566

  Held Feindt, Janka ^a   Hattermann, Kirsten ^b   Müerköster, Susanne Sebens ^a   Wedderkopp, Hanna ^a   Knerlich Lukoschus, Friederike ^a   Ungefroren, Hendrik ^a   Mehdorn, H Maximilian ^a   Mentlein, Rolf ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Chemokine; CX3CR1; Glioma; Microglia Macrophages

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; GELATINASE A; GELATINASE B; GLYCOPROTEIN P 15095; MATRIX METALLOPROTEINASE 14; MESSENGER RNA;

ARTICLE; ASTROCYTOMA; CELL ADHESION; CELL CULTURE; CELL MIGRATION; CELL MOTILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MACROPHAGE; MAJOR CLINICAL STUDY; MICROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR PROMOTION;

EID: 77952890503     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.02.018     Document Type: Article

References (56)

1. Davies F.G., Kupelian V., Freels S., McCarthy B., Surawicz T. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro-Oncology 2001, 3:152-158.
2. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., Belanger K., Brandes A.A., Marosi C., Bogdahn U., Curschmann J., Janzer R.C., Ludwin S.K., Allgeier A., Lacombe D., Cairncross J.G., Eisenhauer E., Mirimanoff R.O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastomas. N. Engl. J. Med. 2005, 352:987-996.
3. Nieder C., Adam M., Grosu A.L. Combined modality treatment of glioblastoma multiforme: the role of temozolomide. Rev. Recent Clin. Trials 2006, 1:43-51.
4. Badie B., Schartner J.M. Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Neurosurgery 2000, 46:957-961.
5. Hussain S.F., Yang D., Suki D., Aldape K., Grimm E., Heimberger A.B. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor responses. Neuro-Oncology 2006, 8:261-279.
6. Rollins B. Chemokines. Blood 1997, 90:909-928.
7. Miller R.J., Rostene W., Apartis E., Banisadr G., Biber K., Milligan E.D., White F.A., Zhang J. Chemokine action in the nervous system. J. Neurosci. 2008, 28:11792-11795.
8. Ambrosini E., Aloisi F. Chemokines and glial cells: a complex network in the central nervous system. Neurochem. Res. 2004, 29:1017-1038.
9. Hattermann K., Ludwig A., Gieselmann V., Held-Feindt J., Mentlein R. The chemokine CXCL16 induces migration and invasion of glial precursor cells via its receptor CXCR6/Bonzo. Mol. Cell. Neurosci. 2008, 3:133-141.
10. Reiss K., Mentlein R., Sievers J., Hartmann D. Stromal cell-derived factor 1 is secreted by meningeal cells and acts as chemotactic factor on neuronal stem cells of the cerebellar external granular layer. Neuroscience 2002, 115:295-305.
11. Ludwig A., Weber C. Transmembrane chemokines: versatile "special agents" in vascular inflammation. Thromb. Haemost. 2007, 97:694-703.
12. Held-Feindt J., Rehmke B., Mentlein R., Hattermann K., Knerlich F., Hugo H.H., Ludwig A., Mehdorn H.M. Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas. Glia 2008, 56:764-774.
13. Horton L.W., Yu Y., Zaja-Milatovic S., Strieter R.M., Richmond A. Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth. Cancer Res. 2007, 67:9791-9799.
14. Zhou Y., Larsen P.H., Hao C., Yong V.W. CXCR4 is a mayor chemokine receptor on glioma cells and mediates their survival. J. Biol. Chem. 2002, 277:49481-49487.
15. Rubin J.B., Kung A.L., Klein R.S., Chan J.A., Sun Y., Schmidt K., Kieran M.W., Luster A.D., Segal R.A. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13513-13518.
16. Vandercappellen J., Van Damme J., Struyf S. The role of CXC chemokines and their receptors in cancer. Cancer Lett. 2008, 267:226-244.
17. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., Greaves D.R., Zlotnik A., Schall T.J. Fractalkine: a new class of membrane-bound chemokine with a CX3C motif. Nature 1997, 385:640-644.
18. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., Huang D., Kidd G., Dombrowski S., Dutta R., Lee J.C., Cook D.N., Jung S., Lira S.A., Littman D.R., Ransohoff R.M. Control of microglial neuron toxicity by the fractalkine receptor. Nat. Neurosci. 2006, 9:917-924.
19. Imai T., Hieshima K., Haskell C., Baba M., Nagira M., Nishimura M., Kakizaki M., Takagi S., Nomiyama H., Schall T.J., Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997, 91:521-530.
20. Harrison J.K., Jiang Y., Chen S., Xia Y., Maciejewski D., McNamara R.K., Streit W.J., Salafranca M.N., Adhikari S., Thompson D.A., Botti P., Bacon K.B., Feng L. Role of neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:10896-10901.
21. Nishiyori A., Minami M., Ohtani Y., Takami S., Yamamoto J., Kawaguchi N., Kume T., Akaike A., Satoh M. Localization of fraktalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neurons to microglia?. FEBS Lett. 1998, 429:167-172.
22. Somasundaram R., Herlyn D. Chemokines and the microenvironment in neuroectodermal tumor-host interaction. Sem. Cancer Biol. 2009, 19:92-96.
23. Rodero M., Marie Y., Coudert M., Blondet E., Mokhtari K., Rousseau A., Raoul W., Carpentier C., Sennlaub F., Deterre P., Delattre J.Y., Debré P., Sanson M., Combadière C. Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma. J. Clin. Oncol. 2008, 26:5957-5964.
24. Xin H., Kikuchi T., Andarini S., Ohkouchi S., Suzuki T., Nukiwa T., Huqun Hagiwara K., Honjo T., Saijo Y. Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells. Eur. J. Immunol. 2005, 35:1371-1380.
25. Yu Y.R., Fong A.M., Combadière C., Gao J.L., Murphy P.M., Patel D.D. Defective antitumor response in CX3CR1-deficient mice. Int. J. Cancer 2007, 12:316-322.
26. Liu C., Luo D., Streit W.J., Harrison J.K. CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes. J. Neuroimmunol. 2008, 198:98-105.
27. Held-Feindt J., Dörner L., Sahan G., Mehdorn H.M., Mentlein R. Cannabinoid receptors in human astroglial tumors. J. Neurochem. 2006, 98:886-893.
28. Ludwig A., Schulte A., Schnack C., Hundhausen C., Reiss K., Brodway N., Held-Feindt J., Mentlein R. Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells. J. Neurochem. 2005, 93:1293-1303.
29. Golembieski W.A., Ge S., Nelson K., Mikkelsen T., Rempel S.A. Increased SPARC expression promotes U87 glioblastoma invasion in vitro. Int. J. Dev. Neurosci. 1999, 17:463-472.
30. Kakinuma T., Hwang S.T. Chemokines, chemokine receptors, and cancer metastasis. J. Leukoc. Biol. 2006, 79:639-651.
31. Zlotnik A. Chemokines and cancer. Int. J. Cancer 2006, 119:2026-2029.
32. Lu H., Ouyang W., Huang C. Inflammation, a key event in cancer development. Mol. Cancer Res. 2006, 4:221-233.
33. Liang Y., Bollen A.W., Gupta N. CC chemokine receptor-2A is frequently overexpressed in glioblastomas. J. Neuro-Oncol. 2008, 86:153-163.
34. Ehtesham M., Mapara K.Y., Stevenson C.B., Thompson R.C. CXCR4 mediates the proliferation of glioblastoma progenitor cells. Cancer Lett. 2009, 274:305-312.
35. Ehtesham M., Winston J.A., Kabos P., Thompson R.C. CXCR4 expression mediates glioma cell invasiveness. Oncogene 2006, 25:2801-2806.
36. Ben-Baruch A. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev. 2006, 25:357-371.
37. Hulshof S., van Haastert E.S., Kuipers H.F., van den Elsen P.J., De Groot C.J., van der Valk P., Ravid R., Biber K. CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis. J. Neuropathol. Exp. Neurol. 2003, 62:899-907.
38. Hatori K., Nagai A., Heidel R., Ryu J.K., Kim S.U. Fractalkine and fractalkine receptors in human neurons and glial cells. J. Neurosci. Res. 2002, 69:418-426.
39. Ludwig A., Mentlein R. Glial cross-talk by transmembrane chemokines CX3CL1 and CXCL16. J. Neuroimmunol. 2008, 198:92-97.
40. Maciejewski-Lenoir D., Chen S., Feng L., Maki R., Bacon K.B. Characterization of fractalkine in the rat brain cells: migratory and activation signals for CX3CR1-expressiong mircoglia. J. Immunol. 1999, 163:1628-1635.
41. Yoshida H., Imaizumi T., Fujimoto K., Matsuo N., Kimura K., Cui X., Matsumiya T., Tanji K., Shibata T., Tamo W., Kumagai M., Satoh K. Synergistic stimulation, by tumor necrosis factor-alpha and interferon-gamma, of fractalkine expression in human astrocytes. Neurosci. Lett. 2001, 303:132-136.
42. Hughes P.M., Botham M.S., Frentzel S., Mir A., Perry V.H. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 2002, 37:314-327.
43. Sunnemark D., Eltayeb S., Nilsson M., Wallstrom E., Lassmann H., Olsson T., Berg A.L., Ericsson-Dahlstrand A. CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin. J. Neuroinflammation 2005, 2:17.
44. Hundhausen C., Misztela D., Berkhout T.A., Broadway N., Saftig P., Reiss K., Hartmann D., Fahrenholz F., Postina R., Matthews V., Kallen K.J., Rose-John S., Ludwig A. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 2003, 102:1186-1195.
45. Garton K.J., Gough P.J., Blobel C.P., Murphy G., Greaves D.R., Dempsey P.J., Raines E.W. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J. Biol. Chem. 2001, 276:37993-38001.
46. Hundhausen C., Schulte A., Schulz B., Andrzejewski M.G., Schwarz N., von Hundelshausen P., Winter U., Paliga K., Reiss K., Saftig P., Weber C., Ludwig A. Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J. Immunol. 2007, 178:8064-8072.
47. Chapman G.A., Moores K., Harrison D., Campbell C.A., Stewart B.R., Strijbos P.J. Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J. Neurosci. 2000, 20:RC87.
48. Clark A.K., Yip P.K., Grist J., Gentry C., Staniland A.A., Marchand F., Dehvari M., Wotherspoon G., Winter J., Ullah J., Bevan S., Malcangio M. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10655-10660.
49. Kastenbauer S., Koedel U., Wick M., Kieseier B.C., Hartung H.P., Pfister H.W. CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system. J. Neuroimmunol. 2003, 137:210-217.
50. Sporer B., Kastenbauer S., Koedel U., Arendt G., Pfister H.W. Increased intrathecal release of soluble fractalkine in HIV-infected patients. AIDS Res. Hum. Retroviruses 2003, 19:111-116.
51. Hussain S.F., Yang D., Suki D., Grimm E., Heimberger A.B. Innate immune functions of microglia isolated from human glioma patients. J. Transl. Med. 2006, 30(4):15. 10.1186/1479-5876-4-15.
52. Parney I., Waldron J.S., Parsa A. Flow cytometry and in vitro analysis of human glioma-associated macrophages. J. Neurosurg. 2009, 110:572-582.
53. Markovic D.S., Glass R., Synowitz M., Rooijen N., Kettenmann H. Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J. Neuropathol. Exp. Neurol. 2005, 64:754-762.
54. Komohara Y., Ohnishi K., Kuratsu J., Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J. Pathol. 2008, 216:15-24.
55. Shulby S.A., Dolloff N.G., Stearns M.E., Meucci O., Fatatis A. CX3CR1-Fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer Res. 2004, 64:4693-4698.
56. Rao J.S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 2003, 489:489-501.